Skip to main content


Table 2 IDH1 mutation status of secondary GBM samples

From: Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Patient ID Treatment IDH1
P1 Mutated
P2 Mutated
P3 Mutated
P4 Mutated
P5 TMZ Mutated
P6 TMZ Mutated
P7 TMZ Mutated
P8 TMZ Wild-type